83%Confidence
0Views
FDASource
2026-04-05Date
Summary
Rising Pharma's Temozolomide Capsules recall due to stability testing failures indicates potential quality degradation issues that could affect cancer treatment efficacy. This may impact patient trust and create supply vulnerabilities for this important chemotherapy medication.
Actionable: Review stability data for all Rising Pharma products and consider implementing additional quality verification measures.
AI Confidence: 83%
Data Points
firmRising Pharma Holding, Inc.
classificationClass II
statusOngoing
distributionNationwide within the U.S
productProduct label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now